Cargando…
MTHFR Polymorphism Is Associated With Severe Methotrexate-Induced Toxicity in Osteosarcoma Treatment
BACKGROUND: Previous studies have revealed the critical role of methylene tetrahydrofolate reductase (MTHFR) polymorphisms in response to high-dose methotrexate (MTX)-induced toxicity in osteosarcoma patients. However, the conclusions remain controversial. In this setting, we performed a meta-analys...
Autores principales: | Zhang, Wenchao, Liu, Zhongyue, Yang, Zhimin, Feng, Chengyao, Zhou, Xiaowen, Tu, Chao, Li, Zhihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714641/ https://www.ncbi.nlm.nih.gov/pubmed/34976820 http://dx.doi.org/10.3389/fonc.2021.781386 |
Ejemplares similares
-
Effect of Polymorphisms of ABCB1 and MTHFR on Methotrexate-Related Toxicities in Adults With Hematological Malignancies
por: Han, Jian, et al.
Publicado: (2021) -
More severe toxicity of genetic polymorphisms on MTHFR activity in osteosarcoma patients treated with high-dose methotrexate
por: Xie, Lu, et al.
Publicado: (2017) -
MTHFR variant is associated with high-dose methotrexate-induced toxicity in the Chinese osteosarcoma patients
por: Xu, Leilei, et al.
Publicado: (2018) -
A novel necroptosis-related lncRNAs signature effectively predicts the prognosis for osteosarcoma and is associated with immunity
por: Liu, Binfeng, et al.
Publicado: (2022) -
A Novel Glutamine Metabolism-Related Gene Signature in Prognostic Prediction of Osteosarcoma
por: Wan, Lu, et al.
Publicado: (2022)